Update date
31 Mar 2023
Shareable Research Card
IVERIC bio, Inc. Current Ratio
This metric view shows IVERIC bio, Inc. current ratio history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2023
- Latest reported value
- 15.24x
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Mar 2023
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2023.
- Latest reported value on this page: 15.24x.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Current Ratio
Latest reported current ratio: 15.24x. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2023
SEC-backed company facts were refreshed from filings filed on 10 May 2023.
Benchmark Context
How Current Ratio compares with peers
IVERIC bio, Inc. is outside the visible top 120 companies for current ratio in the current sample.
Compared with
Compared with 120 companies reporting current ratio in x. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.4x the current sample midpoint. Current Ratio is up about 23% versus the comparable prior period.
- Nearby companies in this sample: Invesco CurrencyShares Australian Dollar Trust and Invesco CurrencyShares British Pound Sterling Trust.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
IVERIC bio, Inc.: Current Ratio
Latest period: Q1 2023. Period end: 31 Mar 2023. Units: x. Frequency: quarterly.
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Metric Snapshot
- Latest value
- 15.24x
- Coverage range
- 30 Jun 2014 - 31 Mar 2023
- Fact rows
- 36
What This Metric Tells You
- Shows the reported level of current ratio over 30 Jun 2014 - 31 Mar 2023.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 36 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Current Ratio levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Invesco CurrencyShares Australian Dollar Trust (["fxa"]) | 2,984.55x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Australian Dollar Trust Current Ratio |
| 2 | Invesco CurrencyShares British Pound Sterling Trust (["fxb"]) | 2,934.36x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares British Pound Sterling Trust Current Ratio |
| 3 | Invesco CurrencyShares Japanese Yen Trust (["fxy"]) | 2,057.85x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Japanese Yen Trust Current Ratio |
| 4 | Invesco CurrencyShares Swiss Franc Trust (["fxf"]) | 1,012.45x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Swiss Franc Trust Current Ratio |
| 5 | STARRY SEA ACQUISITION CORP (["ssea", "ssear", "sseau"]) | 690.21x | Instant - 31 Dec 2025 | Open STARRY SEA ACQUISITION CORP Current Ratio |
| 6 | Anbio Biotechnology (["nnnn"]) | 344.31x | Instant - 31 Dec 2025 | Open Anbio Biotechnology Current Ratio |
Metric Details
- Metric
- Current Ratio (CurrentRatio)
- Taxonomy
- ratio
- Units tracked
- x
- Frequency coverage
- quarterly
- History range
- 30 Jun 2014 - 31 Mar 2023
- Facts on this page
- 36
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
IVERIC bio, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q1 2023 | 15.24x | +2.87x | +23% | 31 Mar 2023 |
| Q4 2022 | 15.69x | +5.2x | +50% | 31 Dec 2022 |
| Q3 2022 | 14.07x | +5.1x | +57% | 30 Sep 2022 |
| Q2 2022 | 13.8x | +4.91x | +55% | 30 Jun 2022 |
| Q1 2022 | 12.37x | +0.85x | +7.3% | 31 Mar 2022 |
| Q4 2021 | 10.49x | -1.53x | -13% | 31 Dec 2021 |
| Q3 2021 | 8.97x | -4.1x | -31% | 30 Sep 2021 |
| Q2 2021 | 8.89x | -4.19x | -32% | 30 Jun 2021 |
| Q1 2021 | 11.53x | +1.54x | +15% | 31 Mar 2021 |
| Q4 2020 | 12.02x | +1.7x | +16% | 31 Dec 2020 |
| Q3 2020 | 13.07x | +2.69x | +26% | 30 Sep 2020 |
| Q2 2020 | 13.08x | +2.09x | +19% | 30 Jun 2020 |
| Q1 2020 | 9.99x | -2.59x | -21% | 31 Mar 2020 |
| Q4 2019 | 10.32x | -3.62x | -26% | 31 Dec 2019 |
| Q3 2019 | 10.38x | -4.73x | -31% | 30 Sep 2019 |
| Q2 2019 | 10.99x | -3.89x | -26% | 30 Jun 2019 |
| Q1 2019 | 12.57x | +0.87x | +7.4% | 31 Mar 2019 |
| Q4 2018 | 13.94x | +5.68x | +69% | 31 Dec 2018 |
| Q3 2018 | 15.11x | +8.97x | +146% | 30 Sep 2018 |
| Q2 2018 | 14.89x | +9.27x | +165% | 30 Jun 2018 |
| Q1 2018 | 11.71x | +5.72x | +96% | 31 Mar 2018 |
| Q4 2017 | 8.26x | +1.51x | +22% | 31 Dec 2017 |
| Q3 2017 | 6.13x | -1.82x | -23% | 30 Sep 2017 |
| Q2 2017 | 5.62x | -3.15x | -36% | 30 Jun 2017 |
| Q1 2017 | 5.99x | -4.76x | -44% | 31 Mar 2017 |
| Q4 2016 | 6.75x | -6.67x | -50% | 31 Dec 2016 |
| Q3 2016 | 7.95x | -9.6x | -55% | 30 Sep 2016 |
| Q2 2016 | 8.77x | -12.91x | -60% | 30 Jun 2016 |
| Q1 2016 | 10.74x | -7.99x | -43% | 31 Mar 2016 |
| Q4 2015 | 13.42x | -5.75x | -30% | 31 Dec 2015 |
| Q3 2015 | 17.55x | -1.66x | -8.6% | 30 Sep 2015 |
| Q2 2015 | 21.69x | +0.93x | +4.5% | 30 Jun 2015 |
| Q1 2015 | 18.74x | 31 Mar 2015 | ||
| Q4 2014 | 19.17x | 31 Dec 2014 | ||
| Q3 2014 | 19.22x | 30 Sep 2014 | ||
| Q2 2014 | 20.76x | 30 Jun 2014 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.